Impact of UGT1A4, UGT2B7, and UGT2B15 pharmacogenetics on tamoxifen (TAM) metabolism.

被引：0
|
作者：
Lim, Joanne Siok-Liu
Ganchev, Boian
Singh, Onkar
Muerdter, Thomas E.
Yap, Yoon Sim
Ng, Raymond C. H.
Wong, Nan Soon
Schwab, Matthias
Chowbay, Balram
机构：
[1] Natl Canc Ctr, Div Med Sci, Lab Clin Pharmacol, Singapore, Singapore
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[3] Univ Tubingen, Stuttgart, Germany
[4] Natl Canc Ctr, Div Med Sci, Singapore, Singapore
[5] Natl Canc Ctr Singapore, Singapore, Singapore
[6] Natl Canc Ctr, Singapore, Singapore
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2588
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Stereoselective metabolism of racemic carvedilol by UGT1A1 and UGT2B7, and effects of mutation of these enzymes on glucuronidation activity
    Takekuma, Yoh
    Takenaka, Toru
    Yamazaki, Koujiro
    Ueno, Kazuyuki
    Sugawara, Mitsuru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (11) : 2146 - 2153
  • [42] Influence of polymorphisms of UDP-glycosyltransferases (UGT) 2B family genes UGT2B15, UGT2B17 and UGT2B28 on the development of prostate cancer in Korean men
    Se-Ra Lee
    Myoung-Hyun Ahn
    Yung Hyun Choi
    Sun-Hee Leem
    Genes & Genomics, 2016, 38 : 225 - 233
  • [43] Influence of polymorphisms of UDP-glycosyltransferases (UGT) 2B family genes UGT2B15, UGT2B17 and UGT2B28 on the development of prostate cancer in Korean men
    Lee, Se-Ra
    Ahn, Myoung-Hyun
    Choi, Yung Hyun
    Leem, Sun-Hee
    GENES & GENOMICS, 2016, 38 (02) : 225 - 233
  • [44] Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study
    Habibi, Mohsen
    Mirfakhraie, Reza
    Khani, Maryam
    Rakhshan, Azadeh
    Azargashb, Eznollah
    Pouresmaeili, Farkhondeh
    GENE, 2017, 634 : 47 - 52
  • [45] In vitro glucuronidation of mycophenolic acid by human UGTs and the impact of known polymorphisms of UGT1A8, UGT1A9, and UGT2B7
    Bernard, O
    Guillemette, C
    DRUG METABOLISM REVIEWS, 2003, 35 : 53 - 53
  • [46] Association of common polymorphisms in UGT2B15 and UGT2B17 with interindividual variability in substrate glucuronidation.
    Haverfield, E. V.
    Kuttab-Boulos, H.
    Zhang, W.
    Ramirez, J.
    Di Rienzo, A.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S59 - S59
  • [47] Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4
    Turgeon, D
    Carrier, JS
    Lévesque, E
    Beatty, BG
    Bélanger, A
    Hum, DW
    JOURNAL OF MOLECULAR BIOLOGY, 2000, 295 (03) : 489 - 504
  • [48] UGT inhibition studies in the presence or absence of alamethicin: evaluation of UGT1A1 and UGT2B7 inhibition in hlm and recombinant enzymes
    Ejaz, Sadaff
    Yerino, Phyllis
    Babara, Joanna
    Grbac, Robert
    Ogilvie, Brain W.
    Buckley, David B.
    DRUG METABOLISM REVIEWS, 2016, 48 : 90 - 91
  • [49] The Inhibitory Effect of 20(S)-Protopanaxatriol (ppt) Towards UGT1A1 and UGT2B7
    He, Ya-Jun
    Fang, Zhong-Ze
    Ge, Guang-Bo
    Jiang, Peng
    Jin, Hui-Zi
    Zhang, Wei-Dong
    Yang, Ling
    PHYTOTHERAPY RESEARCH, 2013, 27 (04) : 628 - 632
  • [50] Relationship of UGT2B7 genotype with diclofenac hepatotoxicity
    Aithal, GP
    Leathart, JBS
    Dang, TS
    Day, CP
    Daly, AK
    GUT, 2003, 52 (05)
12345